About the Session
Join us for an in-depth exploration of Model Physician Health Programs (PHPs) through firsthand experiences and expert discussions. This session will highlight the transformative impact of PHPs on physician health, emphasizing rehabilitation over discipline, the significance of confidentiality, and the essential role of adequate funding for PHPs and participant treatment. Faculty will provide actionable insights for enhancing collaboration between PHPs and medical boards to support physician recovery and public safety.
About the Speakers
Michael J. Baron, MD, MPH, DFASAM, FAPA, obtained an MD and MPH degrees from Tulane University. He completed his Anesthesiology residency at Washington University in St. Louis and his psychiatry residency at Vanderbilt University. He is board certified in Anesthesiology, Psychiatry and Addiction Medicine. He is a Clinical Assistant Professor of Psychiatry at Vanderbilt University. In 2006, he published original research showing that high dose opioids increased chronic pain scores. Dr. Baron was appointed to the Tennessee Board of Medical Examiners (BME) in 2010 and reappointed in 2015. He helped write many different Tennessee Department of Health rules pertaining to the treatment of pain, prescribing controlled substances, and Office-Based Opioid Treatment. He also served on two workgroups for the Federation of State Medical Boards: Physician Sexual Misconduct and Physician Illness and Impairment. Dr. Baron resigned from the Tennessee BME in January 2017 to accept the Medical Director position of the Tennessee Medical Foundation – Physician’s Health Program. In 2023 he helped write two book chapters: “Fitness for Duty” for the Encyclopedia for Neurological Disorders and “Supporting Patients Working in Safety Sensitive Occupations” for the 4th Edition of the ASAM Criteria. Dr. Baron was installed as President of the FSPHP in May 2024.
Stephen D. Loyd, MD, is an Internal Medicine/Addiction Medicine physician who graduated medical school and residency from the James H. Quillen College of Medicine at East Tennessee State University. He currently serves as President of the Tennessee Board of Medical Examiners. Dr. Loyd was the Assistant Commissioner (Opioid Czar) for Substance Abuse Services in the Tennessee Department of Mental Health and Substance Abuse Services in Governor Bill Haslam’s administration. He has served as an expert witness in more than 20 federal and state cases against physicians who were improperly prescribing controlled substances. Dr. Loyd was named an Advocate for Action by the Office of National Drug Control Policy (ONDCP), an office of the President of the United States. He has delivered 500 educational lectures on addiction and treatment of opioid use disorder and proper prescribing of controlled substances. Dr. Loyd was an original member (still active) of the Treatment of Chronic Pain Guidelines Committee which defined pain treatment for providers in the state of Tennessee. He currently serves as Chief Medical Officer for Cedar Recovery in Tennessee, Chair of the Tennessee Opioid Abatement Council appointed by Tennessee Governor Bill Lee, and the Director of the Office of Drug Control Policy for the state of West Virginia.
About the Moderator
Katie L. Templeton, JD, Chair, Federation of State Medical Boards
As the daughter of a hard-working physician, Ms. Templeton was inspired by her father to “do no harm” at a very early age and, later, to focus on medicine as the cornerstone of her professional legal career. She is a dynamic, skilled attorney with over 18 years’ experience in all phases of healthcare law, litigation, and claims management, focusing on medical outcomes, patient safety, and best practices. Ms. Templeton has served as a public member on the Oklahoma State Board of Osteopathic Examiners for over ten years and as President of the Board from 2020-2022. During her time on the board, she served as a member of the Oklahoma Opioid Task Force and personally authored the best practice guidelines for physicians in the state regarding opioid prescribing and legislative compliance, and best practice guidelines regarding legislation implemented following the Dobbs decision. In May 2020, Ms. Templeton was elected as a Public Member to the FSMB Board of Directors and in 2024 as Chair. Her knowledge and commitment to FSMB, the Oklahoma Osteopathic Board and her law career has allowed her to maximize her efforts in promoting state-based medical regulation and accessibility to quality medical care by all, and to help ensure public protection.
Target Audience
This activity was designed specifically for members and staff of state medical and osteopathic boards, as well as individuals interested in medical regulation.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
Accreditation Statement
The Federation of State Medical Boards is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Federation of State Medical Boards designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Federation of State Medical Boards certifies that non-physicians will receive an attendance certificate stating they participated in the activity that was designated for 1.5 AMA PRA Category 1 Credits™.
Release Date: 04/25/2025
Expiration Date: 04/25/2026 (Date after which this enduring material is no longer accredited for CME credit.)
Disclosure Declaration
As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
All faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity.
None of the planners, speakers, moderators and/or panelists for this activity have relevant financial relationships to disclose with ineligible companies.
Instructions for Participants and Obtaining CME Credit
There is no fee for this activity. To receive credit and receive their certificates, participants must view this CME activity in its entirety and complete the evaluation. The estimated time for completion of this activity is 1.5 hours
System Requirements
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an internet browser capable of playing an HTML5 video.
CLICK HERE TO ACCESS THE RECORDING
| Title |
Distributors may purchase multiple copies of packages to distribute to learners, and follow their progress. Bulk discounts are below.
| Quantity | Price per voucher |
|---|---|
| 1+ | $0.00 |